How do we identify novel treatment for childhood cancer?

PubWeight™: 0.75^‹?›

🔗 View Article (PMID 18989892)

Published in Pediatr Blood Cancer on March 01, 2009

Authors

Peter J Houghton¹

Author Affiliations

1: Department Molecular Pharmacology, St Jude Children's Research Hospital, Memphis, Tennessee 38105-2794, USA.

Articles cited by this ↗

Phase II study of intermediate-dose cytarabine in patients with relapsed or refractory Ewing sarcoma: a report from the Children's Oncology Group. Pediatr Blood Cancer (2009) 2.26